Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Additional Clinical Considerations for Desmoid Tumors
Explore the integration of Desmoid Tumor Working Group recommendations with NCCN guidelines and the importance of shared decision-making in patient care.
EP: 1.Key Background Information on Desmoid Tumors
EP: 2.Exploring the Heterogeneous Nature of Desmoid Tumors
EP: 3.The Role of Molecular Biomarkers in Diagnosing Desmoid Tumors
EP: 4.The Burden and Unmet Needs Associated with Desmoid Tumors
EP: 5.When to Observe Desmoid Tumors
EP: 6.Surgery, Cryotherapy, and Radiotherapy for Desmoid Tumors
EP: 7.Novel Pharmacotherapies and NCCN Guideline Recommendations
EP: 8.Examining a Novel FDA-approved Therapy in Desmoid Tumors
EP: 9.Dose Reducing and Sequencing Therapies in Desmoid Tumors
EP: 10.Insurance Coverage and Patient Education
Now Viewing
EP: 11.Additional Clinical Considerations for Desmoid Tumors
EP: 12.Optimizing Patient Care and the Potential of Artificial Intelligence
EP: 13.Unmet Needs and the Future of Desmoid Tumor Management
Panelists discuss the questions below in this video.
- How do you utilize the recommendations set forth by the Desmoid Tumor Working Group? Is this preferred to NCCN or in conjunction? In your clinical practice, what is the role of shared decision-making in patients with desmoid tumors?Who are the different specialties involved in the management of desmoid tumors and how can multidisciplinary care be optimized?
Related Videos
Related Content
Linking Data to Determine Risk for 30-Day Readmissions in Dementia
December 22nd 2025Article
This study found that certain characteristics in linked electronic health record data across episodes of care can help identify patients with Alzheimer disease and related dementias at high risk of 30-day readmissions.
Read More
